View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Swedish Orphan Biovitrum AB.

ASH: Primary HLH: Diagnosis, Management, and Treatment in the 21st Century

ASH: Primary HLH: Diagnosis, Management, and Treatment in the 21st Century

Friday, December 6, 2019
1:30 PM – 3:30 PM
Lunch and Registration: 12:30 PM – 1:30 PM

Rosen Centre Hotel
Lunch: Grand Ballroom DE, Ballroom Level
Meeting Room: Grand Ballroom DE, Ballroom Level
9840 International Drive
Orlando, FL 32819
Phone: (407) 996-9840


Hemophagocytic lymphohistiocytosis (HLH) is a rare blood disorder mediated by overactivated immune cells. Rare hematologic disorders present a distinct challenge for hematologists and other physicians, and prompt differential diagnosis and initiation of effective treatment are critical to optimizing outcomes for patients with HLH. This satellite symposium will provide physicians who encounter these patients with up-to-date information on the diagnosis, pathobiology, and treatment of primary HLH. The expert faculty panel will review the latest clinical data and ongoing clinical trials with the potential to affect care of patients with HLH. Didactic presentations combined with illustrated case studies will provide the opportunity to apply new information to clinical scenarios, equipping participants with the tools to utilize emerging data to optimize care of their patients with HLH.

Benefits of Attending:

  • Gain an understanding of cutting-edge data regarding optimal treatment strategies for patients with HLH.
  • Hear expert perspectives on how to integrate current and emerging agents into clinical practice.
  • Challenge your treatment decision making for patients with HLH through interactive expert review of patient case studies.
  • Learn about clinically relevant advances in the understanding of HLH pathobiology.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Swedish Orphan Biovitrum AB.

Target Audience

This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals interested in the latest advances in the treatment of patients with HLH. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of patients with hematologic malignancies are also invited to attend.

Learning Objectives

  • Identify key diagnostic criteria and strategies for the differential diagnosis of HLH.
  • Evaluate clinical trial data regarding safety and efficacy for emerging therapies and treatment strategies for HLH in the frontline and later-line settings.
  • Integrate emerging options for treatment of patients with HLH into the real-world clinical setting.

Program Chair

Michelle L. Hermiston
Michelle L. Hermiston, MD, PhD
Associate Professor
Department of Pediatrics
UCSF School of Medicine
Pediatric Hematologist and Oncologist
Benioff Children's Hospital
University of California, San Francisco
San Francisco, CA

ASH CME Programs


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By